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Objectives: Patients undergoing reduction mammoplasty (RM) bear the risk of having 
occult breast cancer nests. The detection rate of malignant neoplasms in the resected 
specimens, varies greatly in the literature. The aim of our present study was to analyze risk 
factors and evaluate histopathological findings in our cohort of patients who underwent 
RM towards our center.
Material and methods: In this retrospective single center study we analyzed 559 female 
patients [median age 35.99 (±13.34)] who underwent RM between 2000 and 2010. 
The presence of carcinoma and ductal- (DCIS) or lobular carcinoma in situ (LCIS) were 
considered as pathological findings. Body mass index (BMI), age, surgical technique 
and mass of resected tissue were included into the analysis.
Results: There were 6 cases of occult neoplasia (1.08 %) including 2 cases of breast 
cancer, one multicentric DCIS and 3 cases of LCIS (0.54 %) in 559 patients. Patients 
with breast cancer showed a significant increased median age: 49y median (IQR ± 18) 
vs. 35y (IQR ± 21) (p = 0.004) and a trend towards increased BMI: 25.88 median 
(IQR ± 7.3) vs. 24.50 (IQR ± 4.09) (p = 0.219), compared to patients without pathological 
results. One patient with occult carcinoma had a negative preoperative mammography, 
a patient with LCIS a negative preoperative breast ultrasound.
Conclusions: In our study the occurrence of occult neoplasia was associated with 
increased age and showed a trend towards increased BMI when compared to patients 
without pathological findings. The study demonstrates the necessity of thorough medical 
history, preoperative diagnostic screening and histopathological analysis of all resected 
specimens.
Keywords: mammaplasty, breast cancer, histopathological analysis, retrospective studies, ductal carcinoma in 
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intrODuctiOn
Breast reduction mammoplasty (RM) is a surgical intervention to reduce the volume and change the 
shape of the female breast. Indications include symptomatic macromastia, aesthetic reasons such 
as congenital or acquired asymmetry, or accompanying mastoptosis. The most common indication 
for breast reduction is symptomatic macromastia with patients suffering from neck pain, back 
pain, inframammary intertrigo and shoulder grooving. Different studies have shown the efficacy of 
mammoplasty for the treatment of symptomatic macromastia (1) with good long time results regarding 
pain relief and quality of life (2). For this reason, RM for symptomatic macromastia mostly takes part 
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of third party reimbursement by health insurances. Recent studies 
showed therapeutic effects of RM on headache and migraines and 
suggested broader indication criteria (3). Other indications are 
congenital or acquired breast asymmetry, the latter mostly due to 
previous surgical interventions.
In the collective of patients undergoing breast reduction surgery, 
neoplastic changes of breast tissue are not primary expected. 
However, breast cancer is the most common malignant non-
skin tumor in Swiss women (4) and the presence of occult breast 
cancer in reduction mammoplasty specimens has been described 
before (5–7). Therefore, the assessment of risk factors for the 
development of breast cancer and preoperative examinations 
(e.g., mammography) provide important data before surgery. In 
reduction mammoplasty, the presence of a contralateral breast 
cancer was found to be a major risk factor for the presence of occult 
carcinoma (8, 9). Different parameters to estimate the individual 
probability to develop malignant breast cancer are known (10) 
and should be part of every preoperative assessment of patients 
undergoing RM. Prior to surgery, information about age, age at 
menarche, age at first live birth and number of first-degree relatives 
with breast cancer should be assessed.
Between 2000 and 2010 different surgical techniques where 
described to make procedures simpler and to spare scarring (11–13) 
The aim of this study was to assess individual risk factors of patients 
with the finding of occult breast cancer and compare them to 
patients without malignant findings in reduction mammoplasties.
Patients and Methods
This study was approved by the local ethics committee (KEK-ZH 
Nr.2011-0469). We reviewed the charts of 559 female patients, who 
underwent reduction mammoplasties between 2000 and 2010. 
Inclusion criteria were bilateral breast reduction mammaplasty 
and histological evaluation of resected specimens. Exclusion 
criteria were patients with a history of breast cancer or unilateral 
breast reductions. Preoperative screening reports were reviewed 
and patients with suspicious findings [BIRADS >3 (Breast Imaging 
Reporting and Data System)] excluded. Surgery was performed 
by different surgeons and using different surgical techniques. 
Surgical techniques included those described by Hall-Findlay (13), 
Lassus (11), Mc Kissock (14), Pitanguy (15) and Webster. Additional 
collected parameters were: age at surgery, BMI, preoperative 
mammography/ultrasound, reduction specimen weight and the 
presence of precancerous or malignant findings in the resected 
tissue.
All specimens were assessed by a board-certified pathologist. 
The tissue underwent macroscopic evaluation and dissection in 
5 mm slices. Macroscopic suspicious areas underwent further 
microscopic analysis and processing. Results of histopathologic 
analysis were reviewed and diagnosis for carcinoma, LCIS or DCIS 
collected. Lobular hyperplasia was not considered.
statistical analysis
Data was analyzed using Statistical Package for Social Sciences 
(SPSS, Version 20 for Macintosh; Chicago, Illinois). Discrete values 
were expressed as counts (percentages) and continuous variables 
as medians (IQR). Log10 transformation of age and BMI was 
employed to reach Gaussian distribution of data for parametric 
analysis. Univariate ANOVA was used to test for influence of age 
and diabetes on the occurrence of breast cancer. All tests were two 
tailed; p < 0.05 was considered significant.
results
A total of 566 patients underwent RM between 2000 and 2010 
of which 559 were included in this study. Three of the excluded 
patients had a history of breast cancer, 4 patients underwent 
unilateral procedures. The median BMI was 25.88 kg/m2, median 
Figure 1 | (a) Preoperative screening of patients undergoing reduction mammoplasties between 2000 and 2010. 16% of all patients underwent preoperative 
mammography, only 1% preoperative ultrasound of the breast. 83% had no preoperative radiologic diagnostic. (B) Demonstrates the surgical techniques applied, 
the majority of patients was operated according to the technique described by Lassus. 
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age at surgery was 35 years. 16% of all operated patients underwent 
preoperative mammography, 0,5% preoperative ultrasound 
examination (Figure  1). None of the patients had suspicious 
findings in the preoperative mammography or ultrasound 
exceeding BIRADS 1. Surgical techniques performed were those 
described by Lassus (59%), followed by the Hall-Findlay (18%) 
and those described by Pitanguy (10%) and Mc Kissock (10%). 
Modified techniques described by Hofmann (0.9%) (16) or free 
nipple grafts (2%) (17) were performed less often. The mean 
resection weight was 481,5 (± 300.01 g/breast). Surgical technique 
and weight of the resected tissue was not associated with increased 
occurrence of malignant histological findings. 50 Patients (8.9%) 
were between the age 16 and 19 with the diagnosis of juvenile 
macromastia; none of these patients had malignant findings in 
their reduction specimen.
A total of 6 occult malignancies was found among the 559 
patients included in the study. These findings included two cases 
of occult carcinoma, one multicentric DCIS and three findings 
of LCIS. Patient with findings of occult breast cancer showed a 
tendency towards increased BMI 25.88 median (IQR ± 7.3) vs. 24.50 
(IQR ± 4.09) (p = 0.219), and a significant higher age: 49y median 
(IQR ± 18) vs. 35y (IQR ± 21) (p = 0.004) compared with patients 
without pathological findings. In all three patients with malignant 
findings, oncologic resection in form of conventional mastectomy (n 
= 2) or skin sparing mastectomy (n = 1) was performed, two patients 
underwent additional axillary lymphadenectomy. In all three patients 
an immediate autologous breast reconstruction was performed 
(Table 1). All three patients had a tumor-free follow up for the next 
5 years (Table 1). Interestingly, patients number 2 and 3 (Table 1) 
had a preoperative mammography. In patient number 3 nodular 
mastopathy was describe without further suspicious lesions, in patient 
number 2 the mammography showed no suspicious findings. The 
three patients with a diagnosis of LCIS were closely observed using 
radiologic and clinical evaluation. None of these patients developed 
breast cancer in the following 4 years. The follow up consisted in chart 
reviews of 4 years after surgery.
DiscussiOn
In our study, the rate of occult malignancies among 559 patients 
undergoing RM was 1.08% over a period of 10 years. A number of 
studies over the past years showed variable rates of occult breast 
cancer in RM, varying from 0.03 to 5.45% (6, 7, 18–20). The 
variance of these results is probably the consequence of different 
methodologies and study designs. Some studies treat the LCIS as 
a separate group of histopathologic findings in RM, representing 
a risk factor for development of invasive cancer in either breast 
(8). In spite of these facts, trends in the distribution of pathologic 
findings among patients can be detected. In this study patients 
with malignant findings were significantly older than patients 
without malignancies. This correlates with findings Ambaye et 
al. (5) were almost all malignant occult malignancies were found 
in patients older than 40 years of age. In a subgroup analysis by 
Hassan and Pacifico (18) all significant findings were detected in 
patients over 29 years old with an increasing risk with age. This 
study included patients undergoing symmetrizing mammoplasty 
after contralateral breast cancer, a group we excluded in our study.
In our study patients with breast cancer had a tendency towards 
a higher BMI compared to patients without malignant findings. 
There is evidence for a relationship between increased risk for breast 
cancer, especially for postmenopausal patients with increased 
BMI (21, 22). A prospective analysis of 103.344 postmenopausal 
women by Lahmann et al. (23) demonstrated association 
between weight, BMI and hip circumference in postmenopausal 
patients without hormone replacement therapy. This trend was 
not observed in premenopausal woman. These findings line out 
that postmenopausal woman with increased weight should be 
thoroughly assessed preoperatively.
In breast reduction surgery, the histopathologic assessment 
of resected breast tissue specimens is still subject of debate (18). 
Resected specimens are often fragmented and do not always 
have orientation markings. The appearance of the resected tissue 
is dependent on the surgical technique, the surgical team and 
additional intraoperative resections, to obtain a good shape and 
symmetric results of the breast. The surgical technique should be 
clearly defined for the pathologist to improve orientation on the 
specimen. In contrast to the defined histopathological guidelines 
(24) for the analysis of skin sparing mastectomy specimens, or 
conventional mastectomy specimens, there are no clear rules 
how to mark and assess reduction mammoplasty specimens. 
The focus of the histopathologic examination is commonly 
influenced by macroscopic suspicious areas in the resected tissue. 
Histological analysis thus comprises commonly exemplary areas 
of the specimen and not its entirety. Ambaye et al. (5) showed that 
increased sampling and additional histopathologic sections lead to 
higher detection rates of pathologic findings in RM specimens, but 
are associated with higher costs. These costs could be reduced by 
limiting extra sections on patients with a high-risk profile for the 
presence of occult malignancies. Precise marking and orientation of 
the resected RM specimens by the surgeon allows the pathologist to 
localize pathologic findings more adequately. An additional benefit 
of additional anatomical marking is the potential prevention of 
lumpectomy, allowing for breast conserving therapy in patients 
with low stage tumors (25).
The role of tobacco smoking in the development of breast cancer 
remains unclear. Some authors described smoking cessation to be 
associated with an increase in risk of breast cancer relative to that 
in current smokers, and suspect a “antiestrogenic” or other effects 
taBle 1  | Malignant findings among resection mammoplasty patients and 
oncologic surgery
age BMi Diagnosis Oncologic surgery Breast recon-
struction
1 50–55 33.5 Adeno 
carcinoma (r), 
Stage 2a
Mastectomy, 
LAD (r)
Pedicled lat. dorsi 
flap (r)
2 45–50 33.6 Multic. DCIS 
(b), Stage 1a
s.s.Mastectomy (b) Free m. gracilis 
flap (b)
3 60–65 29.8 Ductal 
carcinoma (r)
Mastectomy, LAD (r) Pedicled lat. dorsi 
flap (r)
(r) right, (b) bilateral. Patients one and three underwent axillary lymphadenectomy (LAD) 
and conventional mastectomy, while in patient number 2 a skin sparing mastectomy 
was performed. All patients had a tumor free follow up.
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